Toronto-based
Aleafia Health Inc.(TSX-V.ALEF) has reported its financial results for the fourth quarter of 2020 (Q4 2020) and fiscal year (FY 2020).
Financial Highlights:
- 233% increase in Q/Q cannabis net revenue
- $4.3 million positive adjusted EBITDA in Q4 2020
- 42% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectively
- Significant product portfolio expansion with 31 new SKUs launched since October.
Aleafia Health CEO Geoffrey Benic commented:
“Following the successful licensing of all three of our production facilities in 2020, we’ve now introduced innovative new cannabis derivative and dried flower formats under a distinct and compelling brand family. Our expanded product portfolio is having an immediate impact, with record quarterly revenue and strong sequential growth in our priority adult-use, medical and international cannabis sales.”
Complete story
here.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.